Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Ovid Therapeutics Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +20 vs. Q4 2025
- Shares held
- 105.1M
- +46.4M (+79.0%) vs. Q4 2025
- Total value
- $233.2M
- +$138.0M (+145.0%) vs. Q4 2025
- New holders
- 30
- 33 more added
- Sold out
- 10
- 20 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OVID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 130 | $395.5M |
| Q1 2026 | 103 | $233.2M |
| Q4 2025 | 84 | $100.2M |
| Q3 2025 | 81 | $47.1M |
| Q2 2025 | 71 | $11.9M |
| Q1 2025 | 82 | $14.5M |
| Q4 2024 | 82 | $44.4M |
| Q3 2024 | 75 | $54.7M |
| Q2 2024 | 74 | $35.4M |
| Q1 2024 | 81 | $152.8M |
| Q4 2023 | 77 | $166.3M |
| Q3 2023 | 64 | $162.6M |
| Q2 2023 | 69 | $134.5M |
| Q1 2023 | 61 | $99.8M |
| Q4 2022 | 60 | $71.7M |
| Q3 2022 | 59 | $65.5M |
| Q2 2022 | 55 | $74.5M |
| Q1 2022 | 62 | $110.3M |
| Q4 2021 | 67 | $109.2M |
| Q3 2021 | 72 | $112.9M |
| Q2 2021 | 80 | $130.5M |
| Q1 2021 | 88 | $145.7M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Ovid Therapeutics Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 10,636,318 | $23.6M | 1.38% | +3,486,318+48.8% | Added |
| Janus Henderson Group PLC | 10,714,000 | $23.7M | 0.01% | +10,714,000 | New |
| Ra Capital Management, L.P. | 10,714,000 | $23.8M | 0.25% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,231,698−100.0% | Sold out |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −899,200−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −239,200−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −127,459−100.0% | Sold out |
| Nine Masts Capital Ltd | 0 | $0 | 0.00% | −13,960−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,676−100.0% | Sold out |
| Sepio Capital, LP | 0 | $0 | 0.00% | −10,145−100.0% | Sold out |
| North Star Investment Management Corp. | 0 | $0 | 0.00% | −1,043−100.0% | Sold out |
| Tradewinds Capital Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |